BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.18.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Global Biodefense
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230824
DTEND;VALUE=DATE:20230826
DTSTAMP:20230802T184221Z
CREATED:20230802T184151Z
LAST-MODIFIED:20230802T184221Z
UID:57441-1692835200-1693007999@globalbiodefense.com
SUMMARY:NIAID Review of BAA Proposals for Development of Diagnostics for Biodefense\, AMR\, and Emerging Infectious Diseases
DESCRIPTION:A closed meeting of the National Institute of Allergy and Infectious Diseases (NIAID) Special Emphasis Panel will be held August 24-25\, 2023 to review and evaluate contract proposals for the NIAID 2023 DMID Omnibus BAA (HHS–NIH–NIAID–BAA2023–1)\, Research Area 004—Development of In Vitro Diagnostics for Biodefense\, Antimicrobial Resistant Infections\, and Emerging Infectious Diseases (N01). \nThe meeting will be closed to the public in accordance with U.S. policies as the contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material\, and personal information concerning individuals associated with the contract proposals\, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. \nThe proposals support the development of promising diagnostics technologies for detection of signatures from biothreat pathogens and pathogens causing emerging\, reemerging\, and AMR infectious diseases\, and for pandemic preparedness. \n\nNext-generation Nucleic Acid Sequencing on Portable Systems\nRapid Protein Detection\nBacterial Identification and Phenotypic Antimicrobial Resistance Characterization.\n\nFederal Register announcement
URL:https://globalbiodefense.com/event/niaid-panel-review-of-baa-proposals-for-development-of-in-vitro-diagnostics-for-biodefense-amr-and-emerging-infectious-diseases/
CATEGORIES:Government Hosted
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230828T130000
DTEND;TZID=America/New_York:20230828T150000
DTSTAMP:20230713T151512Z
CREATED:20230713T150933Z
LAST-MODIFIED:20230713T151512Z
UID:57316-1693227600-1693234800@globalbiodefense.com
SUMMARY:National Biodefense Science Board (NBSB) Public Meeting
DESCRIPTION:The National Biodefense Science Board (NBSB) will convene for a virtual meeting on 28 August 2023. \nThe NBSB provides expert advice and guidance to the U.S. Department of Health and Human Services and the Assistant Secretary of Preparedness and Response regarding current and future chemical\, biological\, radiological\, and nuclear threats\, as well as other matters related to disaster preparedness and response. ASPR manages and convenes the NBSB on behalf of the Secretary of HHS. \nThe public and expert stakeholders are invited to observe the meeting. Pre-registration (Zoom) is required. Anyone may submit questions and comments to the NBSB by email before the meeting. \nRepresentatives from industry\, academia\, health professions\, health care consumer organizations\, non-Federal Government agencies\, or community-based organizations may request up to seven minutes to speak directly to the Board. Requests to speak to the Board will be approved in consultation with the Board Chair and based on time available during the meeting. \nAbout the National Biodefense Science Board\nThe National Biodefense Science Board (NBSB) is a federal advisory committee that provides advice and guidance to assistant secretary for preparedness and response within the U.S. Department of Health and Human Services (HHS)\, and to the HHS secretary on preventing\, preparing for\, and responding to adverse health effects of emergencies. \nThe committee was formerly known as the National Preparedness and Response Science Science Board. The new title more accurately reflects the board’s work\, expertise\, and contributions to the HHS and to the nation’s health resilience. \nThe board was created and given authorities under the Pandemic and All-Hazards Preparedness Act of 2006 and chartered in 2007. The Pandemic and All Hazards Preparedness Reauthorization Act of 2013 (PAHPRA) amended the board’s authorities by broadening membership to include a representative with pediatric expertise and a state\, tribal\, territorial\, or local public health official and expanding the board’s duties to consist of providing specified information to appropriate committees of Congress. These changes\, as well as the board’s new name\, are reflected in the September 2016 charter. \nThe board has 13 voting members with a broad range of expertise in science\, medicine\, and public health. \nPlease visit the NBSB website to register to attend.
URL:https://globalbiodefense.com/event/national-biodefense-science-board-nbsb-public-meeting/
CATEGORIES:Government Hosted
LOCATION:
END:VEVENT
END:VCALENDAR